`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`
`v.
`
`CIPLA LTD.
`Patent Owner
`
`Patent No. 8,168,620
`Issue Date: May 1, 2012
`Title: COMBINATION OF AZELASTINE AND STEROIDS
`_______________
`
`Inter Partes Review No. IPR2017-00807
`
`PETITIONER’S NOTICE OF DEPOSITION OF DR. ALEXANDER
`DOMINIC D’ADDIO UNDER 37 C.F.R. § 42.53
`
`
`
`PLEASE TAKE NOTICE that pursuant to 37 C.F.R. § 42.53, Petitioner
`
`ARGENTUM PHARMACEUTICALS LLC will conduct the cross-examination of
`
`Patent Owner’s declarant, Dr. Alexander Dominic D’Addio. In accordance with
`
`37 C.F.R. § 42.53(d)(1), the parties have conferred and agreed that the cross-
`
`examination will take place on February 21, 2018, commencing at 9:00 a.m. (ET),
`
`and will be held at the offices of Sterne, Kessler, Goldstein & Fox, 1100 New York
`
`Ave NW, Ste 600, Washington, DC 20005.
`
`The cross-examination will be taken before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded by stenographic, audio
`
`and/or audiovisual means. The arrangements for the court reporter will be made
`
`by counsel for Petitioner ARGENTUM PHARMACEUTICALS LLC.
`
`Dated: February 14, 2018
`
`By: /Michael R. Houston/
`
`Michael R. Houston
`Reg. No. 58,486
`Counsel for Petitioner
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing
`
`PETITIONER’S NOTICE OF DEPOSITION was served on February 14, 2018
`
`on Counsel for Patent Owner via electronic mail to the following:
`
`dvarughe-PTAB@skgf.com
` dsterlin-PTAB@skgf.com
` alarock-PTAB@skgf.com
` ueverett-PTAB@skgf.com
`
`Dated: February 14, 2018
`
`By: /Michael R. Houston/
`
`Michael R. Houston
`Reg. No. 58,486
`Counsel for Petitioner
`
`3
`
`